Labcorp announces 2023 second quarter results

Company provides full-year guidance labcorp completed the spin-off of fortrea on june 30, which is treated as discontinued operations in the historical financials announced a $1.0 billion accelerated share repurchase program drove growth through new and expanded healthcare system partnerships second quarter revenue grew 4% versus last year as the base business grew 13%. results from continuing operations for second quarter versus last year: revenue: $3.0 billion versus $2.9 billion diluted eps: $1.74 versus $2.89 adjusted eps: $3.42 versus $4.04 free cash flow: $177 million versus $408 million full-year 2023 guidance from continuing operations: adjusted eps of $13.00 to $14.00 and free cash flow of $0.8 billion to $1.0 billion burlington, n.c.
LH Ratings Summary
LH Quant Ranking